HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Colonization by Helicobacter pylori of leprosy patients in Spain: immunomodulation to low molecular weight antigens of H. pylori.

Abstract
We studied the prevalence of Helicobacter pylori in patients with leprosy and the effects of co-infection on the immune response to Helicobacter antigens in the polar groups of leprosy (lepromatous and tuberculoid). We showed that there is no difference in the prevalence of H. pylori in patients with leprosy as compared to a non-leprosy population. We also demonstrated that the immune response to low molecular weight H. pylori antigens (35, 26 and 19 kDa) differs in patients with lepromatous as compared to those with tuberculoid leprosy. In lepromatous leprosy, we show that there is a higher prevalence of the 35 and 26 kDa antigens, but a lower prevalence of the 19 kDa antigen. These immunological results are consistent with previous histopathological studies illustrating a more severe gastrointestinal inflammation in lepromatous patients; importantly, a response to the 35 kDa antigen is recognized as a marker for the development of ulcerative disease.
AuthorsNeluka Fernando, Pedro Torres, Dino Vaira, John Holton
JournalMemorias do Instituto Oswaldo Cruz (Mem Inst Oswaldo Cruz) Vol. 105 Issue 5 Pg. 682-6 (Aug 2010) ISSN: 1678-8060 [Electronic] Brazil
PMID20835617 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Bacterial
  • Antigens, Bacterial
Topics
  • Adult
  • Aged
  • Antibodies, Bacterial (analysis, immunology)
  • Antigens, Bacterial (immunology)
  • Blotting, Western
  • Case-Control Studies
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Gastritis (complications, immunology, microbiology)
  • Helicobacter Infections (complications, immunology, microbiology)
  • Helicobacter pylori (immunology)
  • Humans
  • Immunomodulation (immunology)
  • Leprosy, Lepromatous (complications, immunology, microbiology)
  • Leprosy, Tuberculoid (complications, immunology, microbiology)
  • Male
  • Middle Aged
  • Spain

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: